Montagu Acquires Majority Stake in HTL Biotechnology

Montagu Acquires Stake in Intech (Orthopaedic Medical Device Manufacturer)

July 12, 2021

Medical Devices

Montagu, a European private equity firm, has entered into and closed a strategic investment in Intech, the France-based global leader in contract manufacturing of orthopaedic surgical instruments. The transaction follows negotiations with existing investors Eurazeo PME and Andera Partners and will see Montagu support Intech’s management to accelerate organic and external growth, expand capacity, and strengthen its position in orthopaedics.

HTL Biotechnology Acquires Modern Meadow's Beauty & Biomedical Division

May 6, 2024

Biotechnology

HTL Biotechnology has acquired the beauty and biomedical division of American company Modern Meadow, including its recombinant proteins platform and leading human recombinant collagen type III (rhCOL3) technology. The deal expands HTL's biopolymer portfolio and R&D/manufacturing capabilities, strengthens its presence in North America, and accelerates development of cosmetic and medical-grade recombinant collagen products.

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.

THG PLC Acquires Bentley Laboratories LLC

May 10, 2021

Manufacturing

THG PLC has agreed to acquire Bentley Laboratories LLC from The Riverside Company and Norgate Holdings. Bentley is a US-based developer and manufacturer of prestige skincare and haircare products with extensive formulation and manufacturing capabilities; the deal strengthens THG's in-house product development and manufacturing for its direct-to-consumer beauty platform and is expected to close following regulatory approval.

Thomas H. Lee Partners' THL Automation Fund Leads $23.5M Growth Investment in Phytech

September 22, 2020

Agriculture

Phytech Ltd., an Israeli digital farming and IoT provider, raised $23.5 million in growth funding from funds managed by Thomas H. Lee Partners (including THL Automation Fund L.P.) and existing anchor investors. The capital will be used to accelerate development of irrigation automation capabilities and support Phytech's global market expansion; THL Managing Director Josh Bresler joined Phytech's board as part of the transaction.

Miura Partners Acquires HTBA (HealthTech BioActives)

November 5, 2024

Biotechnology

Miura Partners has signed an agreement to acquire HTBA (HealthTech BioActives), a Barcelona-headquartered producer of flavonoids and active vitamin B12 used across pharmaceutical, nutraceutical, food & beverage and animal nutrition markets. Miura will pursue organic and inorganic initiatives to consolidate HTBA as a leading platform for natural ingredients; the deal is the third investment from Miura Fund IV and is pending approval from the Spanish regulator.